126 related articles for article (PubMed ID: 1451179)
1. Down-regulation of cell surface CD4 molecule expression induced by anti-CD4 antibodies in human T lymphocytes.
Morel P; Vincent C; Wijdenes J; Revillard JP
Cell Immunol; 1992 Dec; 145(2):287-98. PubMed ID: 1451179
[TBL] [Abstract][Full Text] [Related]
2. Differential functional effects of a humanized anti-CD4 antibody on resting and activated human T cells.
Brett SJ; Rowan W; Smith M; Bartholomew M; Tite JP
Immunology; 1997 Jul; 91(3):346-53. PubMed ID: 9301522
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibody.
Morel P; Nicolas JF; Wijdenes J; Revillard JP
Clin Immunol Immunopathol; 1992 Sep; 64(3):248-53. PubMed ID: 1643758
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
[TBL] [Abstract][Full Text] [Related]
5. Human CD4 modulation in vivo induced by antibody treatment.
Horneff G; Guse AH; Schulze-Koops H; Kalden JR; Burmester GR; Emmrich F
Clin Immunol Immunopathol; 1993 Jan; 66(1):80-90. PubMed ID: 8440076
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
Itoh K; Balch CM; Trial J; Platsoucas CD
Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
[TBL] [Abstract][Full Text] [Related]
7. Dichotomous effect of monocyte Fc receptor interaction on anti-CD3-induced immunoglobulin synthesis.
Wyss T; Bettens F; Walker C; Pichler WJ
Cell Immunol; 1990 Mar; 126(1):91-105. PubMed ID: 2137378
[TBL] [Abstract][Full Text] [Related]
8. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.
Woodle ES; Thistlethwaite JR; Ghobrial IA; Jolliffe LK; Stuart FP; Bluestone JA
Transplantation; 1991 Aug; 52(2):354-60. PubMed ID: 1908148
[TBL] [Abstract][Full Text] [Related]
9. Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules.
Huet S; Boumsell L; Raynal B; Degos L; Dausset J; Bernard A
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7222-6. PubMed ID: 3118361
[TBL] [Abstract][Full Text] [Related]
10. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
11. Cytofluorometric analyses of human T cell CD2/CD4 inter-molecular interactions.
Bueso-Ramos CE; Donahoe RM; Nicholson JK; Madden JJ; Falek A
J Immunol; 1988 Mar; 140(5):1414-20. PubMed ID: 2964474
[TBL] [Abstract][Full Text] [Related]
12. Internalization and degradation of anti-CD4 monoclonal antibodies bound to human peripheral blood lymphocytes.
Morel P; Vincent C; Wijdenes J; Revillard JP
Mol Immunol; 1993 May; 30(7):649-57. PubMed ID: 8098132
[TBL] [Abstract][Full Text] [Related]
13. Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes.
Damle NK; Aruffo A
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6403-7. PubMed ID: 1713678
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD2 antibodies induce T cell unresponsiveness in vivo.
Gückel B; Berek C; Lutz M; Altevogt P; Schirrmacher V; Kyewski BA
J Exp Med; 1991 Nov; 174(5):957-67. PubMed ID: 1682413
[TBL] [Abstract][Full Text] [Related]
15. Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.
Barzaga-Gilbert E; Grass D; Lawrance SK; Peterson PA; Lacy E; Engelhard VH
J Exp Med; 1992 Jun; 175(6):1707-15. PubMed ID: 1534116
[TBL] [Abstract][Full Text] [Related]
16. CD4 mAbs prevent progression of alloactivated CD4+ T cells into the S phase of the cell cycle without interfering with early activation signals.
Fournel S; Vincent C; Assossou O; Gorman SD; Robinet E; Phillips JM; Flacher M; Cordier G; Waldmann H; Revillard JP
Transplantation; 1996 Oct; 62(8):1136-43. PubMed ID: 8900315
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3.
Lin J; Chavin KD; Qin L; Ding Y; Bromberg JS
Cell Immunol; 1996 Feb; 167(2):249-58. PubMed ID: 8603434
[TBL] [Abstract][Full Text] [Related]
18. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
19. A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4.
Anderson D; Chambers K; Hanna N; Leonard J; Reff M; Newman R; Baldoni J; Dunleavy D; Reddy M; Sweet R; Truneh A
Clin Immunol Immunopathol; 1997 Jul; 84(1):73-84. PubMed ID: 9191886
[TBL] [Abstract][Full Text] [Related]
20. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
Huet S; Boumsell L; Dausset J; Degos L; Bernard A
Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
